Orthopediatrics Corp (KIDS) Receives Consensus Recommendation of “Hold” from Brokerages

Orthopediatrics Corp (NASDAQ:KIDS) has received an average recommendation of “Hold” from the six ratings firms that are currently covering the firm, MarketBeat.com reports. Two research analysts have rated the stock with a sell rating and four have assigned a buy rating to the company. The average twelve-month price target among brokers that have updated their coverage on the stock in the last year is $23.67.

KIDS has been the subject of several research reports. Piper Jaffray Companies initiated coverage on shares of Orthopediatrics in a research report on Monday, November 6th. They set an “overweight” rating and a $24.00 price target for the company. BTIG Research initiated coverage on shares of Orthopediatrics in a research report on Monday, November 6th. They set a “buy” rating and a $24.00 price target for the company. Stifel Nicolaus initiated coverage on shares of Orthopediatrics in a research report on Monday, November 6th. They set a “buy” rating and a $23.00 price target for the company. William Blair began coverage on shares of Orthopediatrics in a research report on Monday, November 6th. They set an “outperform” rating for the company. Finally, Zacks Investment Research lowered shares of Orthopediatrics from a “hold” rating to a “sell” rating in a report on Tuesday, January 9th.

Orthopediatrics (NASDAQ:KIDS) traded down $0.66 during midday trading on Friday, hitting $16.48. 26,658 shares of the stock traded hands, compared to its average volume of 35,098. Orthopediatrics has a 12-month low of $16.00 and a 12-month high of $23.00. The company has a quick ratio of 1.00, a current ratio of 2.78 and a debt-to-equity ratio of -0.38.

Orthopediatrics (NASDAQ:KIDS) last released its quarterly earnings results on Wednesday, November 8th. The company reported ($1.70) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.12) by ($1.58). sell-side analysts forecast that Orthopediatrics will post -1.41 EPS for the current fiscal year.

A number of institutional investors have recently added to or reduced their stakes in the stock. Lisanti Capital Growth LLC purchased a new stake in Orthopediatrics in the 4th quarter worth approximately $555,000. Monarch Partners Asset Management LLC purchased a new stake in Orthopediatrics in the 4th quarter worth approximately $339,000. Finally, Kornitzer Capital Management Inc. KS purchased a new stake in Orthopediatrics in the 4th quarter worth approximately $384,000. 1.28% of the stock is owned by institutional investors.

COPYRIGHT VIOLATION NOTICE: This article was first posted by Community Financial News and is the sole property of of Community Financial News. If you are viewing this article on another publication, it was stolen and reposted in violation of US and international copyright law. The original version of this article can be viewed at https://www.com-unik.info/2018/02/08/orthopediatrics-corp-kids-receives-consensus-recommendation-of-hold-from-brokerages.html.

Orthopediatrics Company Profile

OrthoPediatrics Corp. is a medical device company. The Company designs, develops and commercializes orthopedic implants and instruments to meet the specialized needs of pediatric surgeons and their patients. It operates through the OrthoPediatrics segment, which designs, develops and markets implants and devices for children with orthopedic problems.

Receive News & Ratings for Orthopediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthopediatrics and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit